Last reviewed · How we verify
NCT05159414
Study of Application of Pulse Electrical Stimulation Around Eye in Glaucoma Patients
NA trial testing Pulse Electrical Stimulation in Glaucoma in 18 participants. Completed in 12 January 2023.
12 January 2023
Quick facts
| Lead sponsor | Nu Eyne Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 4 May 2021 |
| Primary completion | 12 January 2023 |
| Estimated completion | 12 January 2023 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Pulse Electrical Stimulation
Conditions studied
- Glaucoma — all drugs for Glaucoma →
Sponsor
Nu Eyne Co., Ltd. — full company profile →
Who can join
Adults 19 to 75, any sex, with Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the efficacy and safety of applying pulse electrical stimulation around eyes of glaucoma patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05159414
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Glaucoma
Currently open trials in the same condition.
- NCT07455786 — Modified Trabeculectomy After Failure of Combined Phaco With GATT · NA · recruiting
- NCT07298356 — Automated Applanation Tonometry - Updated · NA · recruiting
- NCT07217678 — Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use · Phase 4 · recruiting
- NCT07145073 — Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies · NA · recruiting
- NCT07209410 — Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanopro · Phase 4 · recruiting
Other Nu Eyne Co., Ltd. trials
Trials by the same sponsor.
- NCT07079215 — Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms · NA · recruiting
- NCT06170411 — Post-marketing Clinical Trial of Elexir(Trigeminal Nerve Electrical Stimulator) for the Acute Treatment of Migraine · NA · unknown
- NCT06120348 — Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser · NA · unknown
- NCT06233279 — Study of Application of Transcutaneous Trigeminal Nerve Stimulation on Autism Spectrum Disorder · NA · unknown
- NCT05259371 — Study of Application of Transcutaneous Pulsed Electrical Stimulation Around Eye in Age-related Macular Degeneration · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05159414 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nu Eyne Co., Ltd.
- Last refreshed: 11 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05159414.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing